Topical immunomodulators for management of oral mucosal conditions, a systematic review; part II: miscellaneous agents

Bibliography

• Elad S, Epstein JB, Yarom N, Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors. Expert Opin Emerg Drugs 2010;15(4):713-26
   PubMed Web of Science ®Google Scholar
• Oxford Center for Evidence-Based Medicine – Levels of Evidence (March 2009). Available from: http://www.cebm.net/index.aspx?o=1025. [Date accessed 3 January 2010]
   Google Scholar
• Nevile B, Damm D, Allen C, Dermatologic diseases. In: Nevile B, Damm D, Allen C, editors, Oral and maxillofacial pathology, 3rd edition. Saunders Elsevier, St. Louis, Missouri; 2009. p. 783
   Google Scholar
• Nevile B, Damm D, Allen C, Allergies and immunologic diseases. In: Nevile B, Damm D, Allen C, editor, Oral and maxillofacial pathology, edition. Saunders Elsevier, St. Louis, Missouri; 2009. p. 333
   Google Scholar
• Rankin KV, Jones DL, Redding SW. Oral health in cancer therapy. A guide for health care professionals. Dental Oncology Education Program; American Cancer Society, Texas Division, Texas Dental Foundation, San Antonio; 2003
   Google Scholar
• Al Johani KA, Hegarty AM, Porter SR, Calcineurin inhibitors in oral medicine. J Am Acad Dermatol 2009;61:829-40
   PubMed Web of Science ®Google Scholar
• Marder W, McCune WJ. Advances in immunosuppressive therapy. Semin Respir Crit Care Med 2007;28:398-417
   PubMed Web of Science ®Google Scholar
• Epstein JB, Gorsky M, Epstein MS, Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:56-61
   PubMed Web of Science ®Google Scholar
• Epstein JB, Nantel S, Sheoltch SM. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. Bone Marrow Transplant 2000;25:683-7
   PubMed Web of Science ®Google Scholar
• Eggleston DJ, Nally FF. Treatment of aphthous ulceration with topical azathioprine. A double blind trial. Br J Oral Surg 1972;9:233-6
   PubMedGoogle Scholar
• Cioli V, Corradino C, Scorza Barcellona P. Review of pharmacological data on benzydamine. Int J Tissue React 1985;7:205-13
   PubMedGoogle Scholar
• Kataoka S, Nishimura K, Naito T. In vivo metabolism and anti-inflammatory activity of benzydamine hydrochloride in rats treated with carrageenin. Chem Pharm Bull (Tokyo) 1979;27:2890-903
   PubMed Web of Science ®Google Scholar
• Segre G, Hammarstrom S. Aspects of the mechanisms of action of benzydamine. Int J Tissue React 1985;7:187-93
   PubMedGoogle Scholar
• Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology 1998;6:95-107
   PubMedGoogle Scholar
• Kim JH, Chu FC, Lakshmi V, Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol 1986;9:132-4
   PubMed Web of Science ®Google Scholar
• Prada A, Lozza L, Moglia D, Effects of benzydamine on radio-polychemotherapeutic mucositis of the oral cavity. Int J Tissue React 1985;7:237-9
   PubMedGoogle Scholar
• Prada A, Chiesa F. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 1987;9:115-19
   PubMedGoogle Scholar
• Kin-Fong Cheng K, Ka Tsui Yuen J. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs 2006;29:423-30
   PubMed Web of Science ®Google Scholar
• Samaranayake LP, Robertson AG, MacFarlane TW, The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 1988;39:291-4
   PubMed Web of Science ®Google Scholar
• Schubert MM, Newton RE. The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. Int J Tissue React 1987;9:99-103
   PubMedGoogle Scholar
• Kazemian A, Kamian S, Aghili M, Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. Eur J Cancer Care (Engl) 2009;18:174-8
   PubMed Web of Science ®Google Scholar
• Epstein JB, Silverman S Jr, Paggiarino DA, Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92:875-85
   PubMed Web of Science ®Google Scholar
• Epstein JB, Stevenson-Moore P. Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg Oral Med Oral Pathol 1986;62:145-8
   PubMedGoogle Scholar
• Epstein JB, Stevenson-Moore P, Jackson S, Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989;16:1571-5
   PubMed Web of Science ®Google Scholar
• Edres MA, Scully C, Gelbier M. Use of proprietary agents to relieve recurrent aphthous stomatitis. Br Dent J 1997;182:144-6
   PubMed Web of Science ®Google Scholar
• Matthews RW, Scully CM, Levers BG, Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1987;63:189-91
   PubMedGoogle Scholar
• Sardella A, Uglietti D, Demarosi F, Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:683-6
   PubMed Web of Science ®Google Scholar
• Wadhwa M, Thorpe R. Haematopoietic growth factors and their therapeutic use. Thromb Haemost 2008;99:863-73
   PubMed Web of Science ®Google Scholar
• Mantovani G, Massa E, Astara G, Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Oncol Rep 2003;10:197-206
   PubMed Web of Science ®Google Scholar
• Sprinzl GM, Galvan O, de Vries A, Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. Eur J Cancer 2001;37:2003-9
   PubMed Web of Science ®Google Scholar
• Hejna M, Kostler WJ, Raderer M, Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial. Eur J Cancer 2001;37:1994-2002
   PubMed Web of Science ®Google Scholar
• van der Lelie H, Thomas BL, van Oers RH, Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study. Ann Hematol 2001;80:150-4
   PubMed Web of Science ®Google Scholar
• Herranz P, Arribas JR, Navarro A, Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor. Br J Dermatol 2000;142:171-6
   PubMed Web of Science ®Google Scholar
• Ibrahim EM, al-Mulhim FA. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Med Oncol 1997;14:47-51
   PubMed Web of Science ®Google Scholar
• Rovirosa A, Ferre J, Biete A. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:747-54
   PubMed Web of Science ®Google Scholar
• Cartee L, Petros WP, Rosner GL, Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study. Cytokine 1995;7:471-7
   PubMed Web of Science ®Google Scholar
• de la Torre A, Reguiero CA, Valcarcel FJ. Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients. Radiother Oncol 1997;43:229-30
   PubMed Web of Science ®Google Scholar
• Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J, A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report. Int J Radiat Oncol Biol Phys 1998;42:551-6
   PubMed Web of Science ®Google Scholar
• Bacanli A, Yerebakan Dicle O, Parmaksizoglu B, Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behcet's disease. J Eur Acad Dermatol Venereol 2006;20:931-5
   PubMed Web of Science ®Google Scholar
• Karthaus M, Rosenthal C, Huebner G, Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial. Bone Marrow Transplant 1998;22:781-5
   PubMed Web of Science ®Google Scholar
• Duggar BM. Aureomycin; a product of the continuing search for new antibiotics. Ann N Y Acad Sci 1948;51:177-81
   PubMed Web of Science ®Google Scholar
• Roberts MC. Tetracycline therapy: update. Clin Infect Dis 2003;36:462-7
   PubMed Web of Science ®Google Scholar
• Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993;28:74-7
   PubMed Web of Science ®Google Scholar
• Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin Exp Dermatol 1995;20:258-9
   PubMed Web of Science ®Google Scholar
• Peoples D, Fivenson DP. Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol 1992;26:498-9
   PubMed Web of Science ®Google Scholar
• Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 1978;7:376-82
   PubMedGoogle Scholar
• Gorsky M, Epstein J, Raviv A, Topical minocycline for managing symptoms of recurrent aphthous stomatitis. Spec Care Dentist 2008;28:27-31
   PubMedGoogle Scholar
• Gorsky M, Epstein J, Rabenstein S, Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. Dermatol Online J 2007;13:1
   PubMedGoogle Scholar
• Guggenheimer J, Brightman VJ, Ship II. Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double-blind controlled trial. J Oral Ther Pharmacol 1968;4:406-8
   PubMedGoogle Scholar
• McDonagh AJ, Gawkrodger DJ, Walker AE. White sponge naevus successfully treated with topical tetracycline. Clin Exp Dermatol 1990;15:152-3
   PubMed Web of Science ®Google Scholar
• Lim J, Ng SK. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol 1992;26:1003-5
   PubMed Web of Science ®Google Scholar
• Otobe IF, de Sousa SO, Migliari DA, Successful treatment with topical tetracycline of oral white sponge nevus occurring in a patient with systemic lupus erythematosus. Int J Dermatol 2006;45:1130-1
   PubMed Web of Science ®Google Scholar
• Otobe IF, de Sousa SO, Matthews RW, White sponge naevus: improvement with tetracycline mouth rinse: report of four cases. Clin Exp Dermatol 2007;32:749-51
   PubMed Web of Science ®Google Scholar
• Becker LR, Lutz C, Erbard H, White sponge naevus successfully treated with tetracycline mouth rinse. Acta Derm Venereol 1997;77:413
   PubMed Web of Science ®Google Scholar
• Walchner M, Messer G, Salomon N, Topical tetracycline treatment of erosive oral lichen planus. Arch Dermatol 1999;135:92-3
   PubMed Web of Science ®Google Scholar
• Bauco van der Wal V, Jonkman MF. Topical tetracycline in cicatricial pemphigoid. J Am Acad Dermatol 1997;36:492-3
   PubMed Web of Science ®Google Scholar
• Gorsky M, Epstein JB. The effect of retinoids on premalignant oral lesions: focus on topical therapy. Cancer 2002;95:1258-64
   PubMed Web of Science ®Google Scholar
• Jones DA. The potential immunomodulatory effects of topical retinoids. Dermatol Online J 2005;11:3
   PubMedGoogle Scholar
• Sloberg K, Hersle K, Mobacken H, Topical tretinoin therapy and oral lichen planus. Arch Dermatol 1979;115:716-18
   PubMed Web of Science ®Google Scholar
• Giustina TA, Stewart JC, Ellis CN, Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 1986;122:534-6
   PubMed Web of Science ®Google Scholar
• Piattelli A, Carinci F, Iezzi G, Oral lichen planus treated with 13-cis-retinoic acid (isotretinoin): effects on the apoptotic process. Clin Oral Investig 2007;11:283-8
   PubMed Web of Science ®Google Scholar
• Buajeeb W, Kraivaphan P, Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:21-5
   PubMed Web of Science ®Google Scholar
• Scardina GA, Messina P, Carini F, A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus. Int J Oral Maxillofac Surg 2006;35:67-71
   PubMed Web of Science ®Google Scholar
• Zegarelli DJ. Treatment of oral lichen planus with topical vitamin A acid. J Oral Med 1984;39:186-91
   PubMedGoogle Scholar
• Piattelli A, Fioroni M, Santinelli A, bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. Oral Oncol 1999;35:314-20
   PubMed Web of Science ®Google Scholar
• Tete S, Pappalardo S, Rubini C, The role of apoptosis and bcl-2 protein in topical treatment of oral leukoplakia with isotretinoin. Minerva Stomatol 1999;48:411-18
   PubMedGoogle Scholar
• Scardina GA, Carini F, Maresi E, Evaluation of the clinical and histological effectiveness of isotretinoin in the therapy of oral leukoplakia: ten years of experience: is management still up to date and effective? Methods Find Exp Clin Pharmacol 2006;28:115-19
   PubMed Web of Science ®Google Scholar
• Epstein JB, Gorsky M. Topical application of vitamin A to oral leukoplakia: A clinical case series. Cancer 1999;86:921-7
   PubMed Web of Science ®Google Scholar
• Scardina GA, Ruggieri A, Messina P. Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. J Oral Sci 2009;51:407-10
   PubMedGoogle Scholar
• Gaspari AA. Mechanism of action and other potential roles of an immune response modifier. Cutis 2007;79:36-45
   PubMed Web of Science ®Google Scholar
• Yasar S, Mansur AT, Serdar ZA, Treatment of focal epithelial hyperplasia with topical imiquimod: report of three cases. Pediatr Dermatol 2009;26:465-8
   PubMed Web of Science ®Google Scholar
• Xiong C, Li Q, Lin M, The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med 2009;38:551-8
   PubMed Web of Science ®Google Scholar
• Meng W, Dong Y, Liu J, A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial. Trials 2009;10:30
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Rubio JA, Sanchez R. Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis. Oral Dis 2007;13:490-4
   PubMed Web of Science ®Google Scholar
• Liu J, Zeng X, Chen Q, An evaluation on the efficacy and safety of amlexanox oral adhesive tablets in the treatment of recurrent minor aphthous ulceration in a Chinese cohort: a randomized, double-blind, vehicle-controlled, unparallel multicenter clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:475-81
   PubMed Web of Science ®Google Scholar
• Murray B, Biagioni PA, Lamey PJ. The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration. J Oral Pathol Med 2006;35:117-22
   PubMed Web of Science ®Google Scholar
• Greer RO Jr, Lindenmuth JE, Juarez T, A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993;51:243-8; discussion 248-9
   PubMed Web of Science ®Google Scholar
• Khandwala A, Van Inwegen RG, Alfano MC. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:222-30
   PubMed Web of Science ®Google Scholar
• Khandwala A, Van Inwegen RG, Charney MR, 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: II. Pharmacokinetics and demonstration of clinical safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:231-8
   PubMed Web of Science ®Google Scholar
• Murray B, McGuinness N, Biagioni P, A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration. J Oral Pathol Med 2005;34:413-19
   PubMed Web of Science ®Google Scholar
• Soria A, Agbo-Bedeau S, Tareb A, Frances C. Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases. Dermatology 2009;21B(1):22-5
   Web of Science ®Google Scholar
• Sironi M, Pozzi P, Polentarutti N, Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 1996;8:710-16
   PubMed Web of Science ®Google Scholar
• Sironi M, Milanese C, Vecchi A, Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int J Clin Lab Res 1997;27:118-122
   PubMedGoogle Scholar
• Guglielmotti A, Aquilini L, Rosignoli MT, Benzydamine protection in a mouse model of endotoxemia. Inflamm Res 1997;46:332-5
   PubMed Web of Science ®Google Scholar
• Ueyama Y, Misaki M, Ishihara Y, Effects of antibiotics on human polymorphonuclear leukocyte chemotaxis in vitro. Br J Oral Maxillofac Surg 1994;32:96-9
   PubMed Web of Science ®Google Scholar
• Kloppenburg M, Verweij CL, Miltenburg AM, The influence of tetracyclines on T cell activation. Clin Exp Immunol 1995;102:635-41
   PubMed Web of Science ®Google Scholar
• Taylor LJ, Bagg J, Walker DM, Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration. J Oral Pathol Med 1992;21:21-5
   PubMed Web of Science ®Google Scholar
• Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006;54:258-65
   PubMed Web of Science ®Google Scholar
• Kang S. The mechanism of action of topical retinoids. Cutis 2005;75:10-13; discussion 13
   PubMed Web of Science ®Google Scholar
• Saijo T, Kuriki H, Ashida Y, Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent. Int Arch Allergy Appl Immunol 1985;78:43-50
   PubMedGoogle Scholar
• Araki K, Youngblood B, Ahmed R. The role of mTOR in memory CA8 T-cell differentiation. Immunol Rev 2010;234(1):234-48
   Google Scholar
• Becker JC, Houben R, Vetter CS, The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer 2006;6:7
   PubMed Web of Science ®Google Scholar
• Mattsson U, Magnusson B, Jontell M. Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:e19-25
   PubMed Web of Science ®Google Scholar